Screening for Rheumatic Heart Disease among Peruvian Children: A Two-Stage Sampling Observational Study

PLoS One. 2015 Jul 24;10(7):e0133004. doi: 10.1371/journal.pone.0133004. eCollection 2015.

Abstract

Background: The objective of the study was to evaluate the implications of different classifications of rheumatic heart disease on estimated prevalence, and to systematically assess the importance of incidental findings from echocardiographic screening among schoolchildren in Peru.

Methods: We performed a cluster randomized observational survey using portable echocardiography among schoolchildren aged 5 to 16 years from randomly selected public and private schools in Arequipa, Peru. Rheumatic heart disease was defined according to the modified World Health Organization (WHO) criteria and the World Heart Federation (WHF) criteria.

Findings: Among 1395 eligible students from 40 classes and 20 schools, 1023 (73%) participated in the present survey. The median age of the children was 11 years (interquartile range [IQR] 8-13 years) and 50% were girls. Prevalence of possible, probable and definite rheumatic heart disease according to the modified WHO criteria amounted to 19.7/1000 children and ranged from 10.2/1000 among children 5 to 8 years of age to 39.8/1000 among children 13 to 16 years of age; the prevalence of borderline/definite rheumatic heart disease according to the WHF criteria was 3.9/1000 children. 21 children (2.1%) were found to have congenital heart disease, 8 of which were referred for percutaneous or surgical intervention.

Conclusions: Prevalence of RHD in Peru was considerably lower compared to endemic regions in sub-Saharan Africa, southeast Asia, and Oceania; and paralleled by a comparable number of undetected congenital heart disease. Strategies to address collateral findings from echocardiographic screening are necessary in the setup of active surveillance programs for RHD.

Trial registration: ClinicalTrials.gov identifier: NCT02353663.

Publication types

  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Anthropometry
  • Antibiotic Prophylaxis
  • Child
  • Child, Preschool
  • Female
  • Health Surveys
  • Heart Defects, Congenital / diagnostic imaging
  • Heart Defects, Congenital / epidemiology
  • Humans
  • Incidental Findings
  • Male
  • Mass Screening*
  • Observer Variation
  • Peru / epidemiology
  • Physical Examination
  • Prevalence
  • Rheumatic Heart Disease / diagnostic imaging
  • Rheumatic Heart Disease / epidemiology*
  • Sampling Studies
  • Socioeconomic Factors
  • Ultrasonography

Associated data

  • ClinicalTrials.gov/NCT02353663

Grants and funding

The study was supported by research grants of the UBS Optimus Foundation and the Gottfried and Julia Bangerter-Rhyner Foundation. Dr. Spitzer received a Research Fellowship of the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology and a Research Grant of the Spanish Society of Cardiology. The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the manuscript.